请输入您要查询的百科知识:

 

词条 AVN-101
释义

  1. See also

  2. References

  3. External links

{{Drugbox
| Verifiedfields =
| Watchedfields =
| verifiedrevid =
| IUPAC_name = 2,8-Dimethyl-5-(2-phenylethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
| image = AVN-101.svg
| width = 150px
| tradename =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref =
| CAS_number =
| CAS_supplemental =
| ATC_prefix =
| ATC_suffix =
| PubChem =
| DrugBank_Ref =
| DrugBank =
| ChEMBL = 592752
| ChemSpiderID_Ref =
| ChemSpiderID = 24643855
| C=21 | H=24 | N=2 | O=
| molecular_weight =
| smiles = Cc1ccc2c(c1)c3c(n2CCc4ccccc4)CCN(C3)C
| StdInChI_Ref =
| StdInChIKey_Ref =
| StdInChI = 1S/C21H24N2/c1-16-8-9-20-18(14-16)19-15-22(2)12-11-21(19)23(20)13-10-17-6-4-3-5-7-17/h3-9,14H,10-13,15H2,1-2H3
| StdInChIKey = IBUHDDLETPJVGP-UHFFFAOYSA-N
| synonyms =
}}AVN-101, a close structural analogue of latrepirdine, is a selective 5-HT6 receptor antagonist which is under development by Avineuro Pharmaceuticals for the treatment of Alzheimer's disease and anxiety disorders.[1][2][3] As of November 2013, it is in phase II clinical trials for these indications.[2][3][4]

See also

  • List of investigational anxiolytics
  • AVN-211

References

1. ^{{cite journal|last1=V. Ivachtchenko|first1=Alexandre|last2=A. Ivanenkov|first2=Yan|title=Small Molecule 5-HT6R Ligands: A Comprehensive Insight into their Selectivity and Activity|journal=Current Bioactive Compounds|volume=9|issue=1|year=2013|pages=64–100|issn=1573-4072|doi=10.2174/1573407211309010007}}
2. ^{{cite journal|last1=Griebel|first1=Guy|last2=Holmes|first2=Andrew|title=50 years of hurdles and hope in anxiolytic drug discovery|journal=Nature Reviews Drug Discovery|volume=12|issue=9|year=2013|pages=667–687|issn=1474-1776|doi=10.1038/nrd4075|pmid=23989795|pmc=4176700}}
3. ^{{cite journal|last1=Benhamú|first1=Bellinda|last2=Martín-Fontecha|first2=Mar|last3=Vázquez-Villa|first3=Henar|last4=Pardo|first4=Leonardo|last5=López-Rodríguez|first5=María L.|title=Serotonin 5-HT6Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer’s Disease|journal=Journal of Medicinal Chemistry|volume=57|issue=17|year=2014|pages=7160–7181|issn=0022-2623|doi=10.1021/jm5003952|pmid=24850589}}
4. ^{{cite web | url = http://adisinsight.springer.com/drugs/800030006 | title = AVN 101 | author = AdisInsight | accessdate = 2015-06-10}}

External links

  • Pipeline - Avineuro Pharmaceuticals, Inc.
  • CNS Platform - AllaChem
  • AVN-101 - AdisInsight
{{Nootropics}}{{Antidementia}}{{Serotonin receptor modulators}}{{nervous-system-drug-stub}}

3 : 5-HT6 antagonists|Anxiolytics|Nootropics

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/21 15:49:11